Ketogenic diets improve behaviors associated with autism spectrum disorder in a sex-specific manner in the EL mouse

Physiology and Behavior

Volumn 168, Issue , 2017, Pages 138-145

  Ruskin, David N ^a   Fortin, Jessica A ^a   Bisnauth, Subrina N ^a   Masino, Susan A ^a  

^a TRINITY COLLEGE   (United States)

Author keywords

Autism spectrum disorder; Comorbidity; EL mouse; Female; Glucose; Grooming; Ketogenic diet; Ketosis; Sex differences; Sociability; Social transmission of food preference; Hydroxybutyrate

Indexed keywords

CARBOHYDRATE; PROTEIN; VITAMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTISM; BEHAVIOR; COMPULSION; CONTROLLED STUDY; FAT INTAKE; FEMALE; FOOD PREFERENCE; GROOMING; INTERPERSONAL COMMUNICATION; KETOGENIC DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; SEIZURE; SOCIAL BEHAVIOR; SYMPTOM; ANALYSIS OF VARIANCE; ANIMAL; COMPLICATION; DIET THERAPY; DISEASE MODEL; EPILEPSY; GENETICS; MENTAL DISORDERS; PROCEDURES; SEXUAL DEVELOPMENT;

ANALYSIS OF VARIANCE; ANIMALS; AUTISM SPECTRUM DISORDER; DISEASE MODELS, ANIMAL; EPILEPSY; FEMALE; KETOGENIC DIET; MALE; MENTAL DISORDERS; MICE; SEX CHARACTERISTICS; SOCIAL BEHAVIOR;

EID: 84995804468     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2016.10.023     Document Type: Article

References (86)

1. [1] Cuccaro, M.L., Tuchman, R.F., Hamilton, K.L., Wright, H.H., Abramson, R.K., Haines, J.L., et al. Exploring the relationship between autism spectrum disorder and epilepsy using latent class cluster analysis. J. Autism Dev. Disord. 42 (2012), 1630–1641.
2. [2] Kantzer, A.K., Fernell, E., Gillberg, C., Miniscalco, C., Autism in community pre-schoolers: developmental profiles. Res. Dev. Disabil. 34 (2013), 2900–2908.
3. [3] Carlsson, L.H., Norrelgen, F., Kjellmer, L., Westerlund, J., Gillberg, C., Fernell, E., Coexisting disorders and problems in preschool children with autism spectrum disorders. TheScientificWorldJOURNAL, 2013, 2013, 213979.
4. [4] Amiet, C., Gourfinkel-An, I., Laurent, C., Bodeau, N., Génin, B., Leguern, E., et al. Does epilepsy in multiplex autism pedigrees define a different subgroup in terms of clinical characteristics and genetic risk?. Mol. Autism, 4, 2013, 47.
5. [5] Doshi-Velez, F., Ge, Y., Kohane, I., Comorbidity clusters in autism spectrum disorders: an electronic health record time-series analysis. Pediatrics 133 (2014), e54–e63.
6. [6] Sansa, G., Carlson, C., Doyle, W., Weiner, H.L., Bluvstein, J., Barr, W., et al. Medically refractory epilepsy in autism. Epilepsia 52 (2011), 1071–1075.
7. [7] Pearson, D.A., Santos, C.W., Aman, M.G., Arnold, L.E., Casat, C.D., Mansour, R., et al. Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms. J. Child Adolesc. Psychopharmacol. 23 (2013), 337–351.
8. [8] Farmer, C., Thurm, A., Grant, P., Pharmacotherapy for the core symptoms in autistic disorder: current status of the research. Drugs 73 (2013), 303–314.
9. [9] Doyle, C.A., McDougle, C.J., Pharmacologic treatments for the behavioral symptoms associated with autism spectrum disorders across the lifespan. Dialogues Clin. Neurosci. 14 (2012), 263–279.
10. [10] Williams, K., Brignell, A., Randall, M., Silove, N., Hazell, P., Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database Syst. Rev., 8, 2013, CD004677.
11. [11] Baribeau, D.A., Anagnostou, E., An update on medication management of behavioral disorders in autism. Curr. Psychiatry Rep., 16, 2014, 437.
12. [12] Ching, H., Pringsheim, T., Aripiprazole for autism spectrum disorders (ASD). Cochrane Database Syst. Rev., 5, 2012, CD009043.
13. [13] Dove, D., Warren, Z., McPheeters, M.L., Taylor, J.L., Sathe, N.A., Veenstra-VanderWeele, J., Medications for adolescents and young adults with autism spectrum disorders: a systematic review. Pediatrics 130 (2012), 717–726.
14. [14] Kinsman, S.L., Vining, E.P., Quaskey, S.A., Mellits, D., Freeman, J.M., Efficacy of the ketogenic diet for intractable seizure disorders: review of 58 cases. Epilepsia 33 (1992), 1132–1136.
15. [15] Kankirawatana, P., Jirapinyo, P., Kankirawatana, S., Wongarn, R., Thamanasiri, N., Ketogenic diet: an alternative treatment for refractory epilepsy in children. J. Med. Assoc. Thail. 84 (2001), 1027–1032.
16. [16] Hallböök, T., Sjolander, A., Amark, P., Miranda, M., Bjurulf, B., Dahlin, M., Effectiveness of the ketogenic diet used to treat resistant childhood epilepsy in Scandinavia. Eur. J. Paediatr. Neurol. 19 (2015), 29–36.
17. [17] Wilder, R.M., High fat diets in epilepsy. Mayo Clin. Bull., 2, 1921, 308.
18. [18] Mike, E.M., Practical guide and dietary management of children with seizures using the ketogenic diet. Am. J. Clin. Nutr. 17 (1965), 399–409.
19. [19] Hassan, A.M., Keene, D.L., Whiting, S.E., Jacob, P.J., Champagne, J.R., Humphreys, P., Ketogenic diet in the treatment of refractory epilepsy in childhood. Pediatr. Neurol. 21 (1999), 548–552.
20. [20] Kang, H.C., Lee, Y.M., Kim, H.D., Lee, J.S., Slama, A., Safe and effective use of the ketogenic diet in children with epilepsy and mitochondrial respiratory chain complex defects. Epilepsia 48 (2007), 82–88.
21. [21] Neal, E.G., Chaffe, H., Schwartz, R.H., Lawson, M.S., Edwards, N., Fitzsimmons, G., et al. A randomized trial of classical and medium-chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia 50 (2009), 1109–1117.
22. [22] Suo, C., Liao, J., Lu, X., Fang, K., Hu, Y., Chen, L., et al. Efficacy and safety of the ketogenic diet in Chinese children. Seizure 22 (2013), 174–178.
23. [23] Martinez, C.C., Pyzik, P.L., Kossoff, E.H., Discontinuing the ketogenic diet in seizure-free children: recurrence and risk factors. Epilepsia 48 (2007), 187–190.
24. [24] Patel, A., Pyzik, P.L., Turner, Z., Rubenstein, J.E., Kossoff, E.H., Long-term outcomes of children treated with the ketogenic diet in the past. Epilepsia 51 (2010), 1277–1282.
25. [25] Boison, D., Sandau, U., Ruskin, D.N., Kawamura, M. Jr., Masino, S.A., Homeostatic control of brain function - new approaches to understand epileptogenesis. Front. Cell. Neurosci., 7, 2013, 109.
26. [26] Muller-Schwarze, A.B., Tandon, P., Liu, Z., Lang, Y., Holmes, G.L., Stafstrom, C.E., Ketogenic diet reduces spontaneous seizures and mossy fiber sprouting in the kainic acid model. Neuroreport 10 (1999), 1517–1522.
27. [27] Todorova, M.T., Tandon, P., Madore, R.A., Stafstrom, C.E., Seyfried, T.N., The ketogenic diet inhibits epileptogenesis in EL mice: a genetic model for idiopathic epilepsy. Epilepsia 41 (2000), 933–940.
28. [28] Su, S.W., Sogawa, M.R.C.Y., Silveira, D.C., Holmes, G.L., Stafstrom, C.E., Timing of ketogenic diet initiation in an experimental epilepsy model. Dev. Brain Res. 125 (2000), 131–138.
29. [29] Hu, X.-L., Cheng, X., Fei, J., Xiong, Z.-Q., Neuron-restrictive silencer factor is not required for the antiepileptic effect of the ketogenic diet. Epilepsia 52 (2011), 1609–1616.
30. [30] Jiang, Y., Yang, Y., Wang, S., Ding, Y., Guo, Y., Zhang, M.-M., et al. Ketogenic diet protects against epileptogenesis as well as neuronal loss in amygdaloid-kindling seizures. Neurosci. Lett. 508 (2012), 22–26.
31. [31] Mantis, J.G., Meidenbauer, J.J., Zimick, N.C., Centeno, N.A., Seyfried, T.N., Glucose reduces the anticonvulsant effects of the ketogenic diet in EL mice. Epilepsy Res. 108 (2014), 1137–1144.
32. [32] Lusardi, T.A., Akula, K.K., Coffman, S.Q., Ruskin, D.N., Masino, S.A., Boison, D., Ketogenic diet prevents epileptogenesis and disease progression in adult mice and rats. Neuropharmacology 99 (2015), 500–509.
33. [33] Evangeliou, A., Vlachonikolis, I., Mihailidou, H., Spilioti, M., Skarpalezou, A., Makaronas, N., et al. Application of a ketogenic diet in children with autistic behavior: pilot study. J. Child Neurol. 18 (2003), 113–118.
34. [34] Spilioti, M., Evangeliou, A.E., Tramma, D., Theodoridou, Z., Metaxas, S., Michailidi, E., et al. Evidence for treatable inborn errors of metabolism in a cohort of 187 Greek patients with autism spectrum disorder (ASD). Front. Hum. Neurosci., 7, 2013, 858.
35. [35] Arvio, M., Kuisma, L., Pöntinen, M., The modified Atkins diet brought back the joy of life to a developmentally severely disabled youth. Duodecim 126 (2010), 557–560.
36. [36] Masino, S.A., Svedova, J., Kawamura, M. Jr., DiMario, F.D. Jr., et al. Adenosine and autism - recent research and a new perspective. Eapen, V., (eds.) Autism - A Neurodevelopmental Journey From Genes to Behaviour, 2011, InTech, Rijeka, Croatia, 103–122.
37. [37] Herbert, M.R., Buckley, J.A., Autism and dietary therapy: case report and review of the literature. J. Child Neurol. 28 (2013), 975–982.
38. [38] Frye, R.E., Sreenivasula, S., Adams, J.B., Traditional and non-traditional treatments for autism spectrum disorder with seizures: an on-line survey. BMC Pediatr., 11, 2011, 37.
39. [39] Ruskin, D.N., Svedova, J., Cote, J.L., Sandau, U., Rho, J.M., Kawamura, M., et al. Ketogenic diet improves core symptoms of autism in BTBR mice. PLoS One, 8, 2013, e65021.
40. [40] Ahn, Y., Narous, M., Tobias, R., Rho, J.M., Mychasiuk, R., The ketogenic diet modifies social and metabolic alterations identified in the prenatal valproic acid model of autism spectrum disorder. Dev. Neurosci. 36 (2014), 371–380.
41. [41] Verpeut, J.L., DiCicco-Bloom, E., Bello, N.T., Ketogenic diet exposure during the juvenile period increases social behaviors and forebrain neural activation in adult Engrailed 2 null mice. Physiol. Behav. 161 (2016), 90–98.
42. [42] Castro, K., Baronio, D., Perry, I.S., Riesgo, R.d.S., Gottfried, C., The effect of ketogenic diet in an animal model of autism induced by prenatal exposure to valproic acid. Nutr. Neurosci., 2016 (in press).
43. [43] Haas, R.H., Rice, M.A., Tauner, D.A., Merritt, T.A., Therapeutic effects of a ketogenic diet in Rett syndrome. Am. J. Med. Genet. Suppl. 1 (1986), 225–246.
44. [44] Bujas-Petković, Z., Matijasić, R., Divcić, B., Rett's syndrome: differential diagnosis in relation to autism with case report. Liječ. Vjesn. 111 (1989), 458–460.
45. [45] Liebhaber, G.M., Riemann, E., Baumeister, F.A., Ketogenic diet in Rett syndrome. J. Child Neurol. 18 (2003), 74–75.
46. [46] Mantis, J.G., Fritz, C.L., Marsh, J., Heinrichs, S.C., Seyfried, T.N., Improvement in motor and exploratory behavior in Rett syndrome mice with restricted ketogenic and standard diets. Epilepsy Behav. 15 (2009), 133–141.
47. [47] Park, M.J., Aja, S., Li, Q., Degano, A.L., Penati, J., Zhuo, J., et al. Anaplerotic triheptanoin diet enhances mitochondrial substrate use to remodel the metabolome and improve lifespan, motor function, and sociability in MeCP2-null mice. PLoS One, 9, 2014, e109527.
48. [48] Ruskin, D.N., Ross, J.L., Kawamura, M. Jr., Ruiz, T.L., Geiger, J.D., et al. A ketogenic diet delays weight loss and does not impair working memory or motor function in the R6/2 1J mouse model of Huntington's disease. Physiol. Behav. 103 (2011), 501–507.
49. [49] Murashima, Y.L., Tada, H., Kasamo, K., Morooka, K., Suzuki, J., Antiepileptic effects of allopurinol involved in hippocampal specific SOD (superoxide dismutase) induction in the mutant EL mouse. Jpn. J. Psychiatry Neurol. 47 (1993), 374–377.
50. [50] Meidenbauer, J.J., Mantis, J.G., Seyfried, T.N., The EL mouse: a natural model of autism and epilepsy. Epilepsia 52 (2011), 347–357.
51. [51] Mantis, J.G., Centeno, N.A., Todorova, M.T., McGowan, R., Seyfried, T.N., Management of multifactorial idiopathic epilepsy in EL mice with caloric restriction and the ketogenic diet: role of glucose and ketone bodies. Nutr. Metab., 1, 2004, 11.
52. [52] Ruskin, D.N., Kawamura, M. Jr., Masino, S.A., Reduced pain and inflammation in juvenile and adult rats fed a ketogenic diet. PLoS One, 4, 2009, e8349.
53. [53] Koranda, J.L., Ruskin, D.N., Masino, S.A., Blaise, J.H., A ketogenic diet reduces long-term potentiation in the dentate gyrus of freely-behaving rats. J. Neurophysiol. 106 (2011), 662–666.
54. 1 receptors. J. Clin. Invest. 121 (2011), 2679–2683.
55. [55] Ruskin, D.N., Suter, T.A.C.S., Ross, J.L., Masino, S.A., Ketogenic diets and thermal pain: dissociation of hypoalgesia, elevated ketones, and lowered glucose in rats. J. Pain 14 (2013), 467–474.
56. [56] Kawamura, M. Jr., Ruskin, D.N., Geiger, J.D., Boison, D., Masino, S.A., Ketogenic diet sensitizes glucose control of hippocampal excitability. J. Lipid Res. 55 (2014), 2254–2260.
57. [57] Masino, S.A., Koranda, J.L., Ruskin, D.N., Blaise, J.H., Effects of a ketogenic diet on hippocampal plasticity in freely-moving juvenile rats. Physiol. Rep., 3, 2015, e12411.
58. [58] Todorova, M.T., Dangler, C.A., Drage, M.G., Sheppard, B.J., Fox, J.G., Seyfried, T.N., Sexual dysfunction and sudden death in epileptic male EL mice: inheritance and prevention with the ketogenic diet. Epilepsia 44 (2003), 25–31.
59. [59] Leussis, M.P., Heinrichs, S.C., Routine tail suspension husbandry facilitates onset of seizure susceptibility in EL mice. Epilepsia, 2006.
60. [60] Moy, S.S., Nadler, J.J., Perez, A., Barbaro, R.P., Johns, J.M., Magnuson, T.R., et al. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav. 3 (2004), 287–302.
61. [61] Bond, T.L., Drage, M., Heinrichs, S.C., Seizure-prone EL mice exhibit deficits in pup nursing and retrieval assessed using a novel method of maternal behavior phenotyping. Epilepsy Behav. 4 (2003), 57–64.
62. [62] Lim, C.E., Turner, L.H., Heinrichs, S.C., Short-term social recognition memory deficit and atypical social and physiological stressor reactivity in seizure-susceptible EL mice. Seizure 16 (2007), 59–68.
63. [63] Turner, L.H., Lim, C.E., Heinrichs, S.C., Antisocial and seizure susceptibility phenotypes in an animal model of epilepsy are normalized by impairment of brain corticotropin-releasing factor. Epilepsy Behav. 10 (2007), 8–15.
64. [64] Greene, A.E., Todorova, M.T., McGowan, R., Seyfried, T.N., Caloric restriction inhibits seizure susceptibility in epileptic EL mice by reducing blood glucose. Epilepsia 42 (2001), 1371–1378.
65. [65] Meidenbauer, J.J., Roberts, M.F., Reduced glucose utilization underlies seizure protection with dietary therapy in epileptic EL mice. Epilepsy Behav. 39 (2014), 48–54.
66. [66] Socała, K., Nieoczym, D., Pieróg, M., Wlaź, P., Role of the adenosine system and glucose restriction in the acute anticonvulsant effect of caprylic acid in the 6 Hz psychomotor seizure test in mice. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 57C (2015), 44–51.
67. [67] Masino, S.A., Kawamura, M. Jr., Plotkin, L.M., Svedova, J., DiMario, F.J., et al. The relationship between the neuromodulator adenosine and behavioral symptoms of autism. Neurosci. Lett. 500 (2011), 1–5.
68. [68] Napoli, E., Dueñas, N., Giulivi, C., Potential therapeutic use of the ketogenic diet in autism spectrum disorders. Front. Pediatr., 2, 2014, 69.
69. [69] Noakes, M., Foster, P.R., Keogh, J.B., James, A.P., Mamo, J.C., Clifton, P.M., Comparison of isocaloric very low carbohydrate/high saturated fat and high carbohydrate/low saturated fat diets on body composition and cardiovascular risk. Nutr. Metab., 3, 2006, 7.
70. [70] Nuttall, F.Q., Almokayyad, R.M., Gannon, M.C., Comparison of a carbohydrate-free diet vs. fasting on plasma glucose, insulin and glucagon in type 2 diabetes. Metabolism 64 (2015), 253–262.
71. [71] Currais, A., Farrokhi, C., Dargusch, R., Goujon-Svrzic, M., Maher, P., Dietary glycemic index modulates the behavioral and biochemical abnormalities associated with autism spectrum disorder. Mol. Psychiatry 21 (2016), 426–436.
72. [72] Zilkha, N., Kuperman, Y., Kimchi, T., High-fat diet exacerbates cognitive rigidity and social deficiency in the BTBR mouse model of autism. Neuroscience, 2016, 10.1016/j.neuroscience.2016.01.070.
73. [73] McDonald, T.S., Tan, K.N., Hodson, M.P., Borges, K., Alterations of hippocampal glucose metabolism by even versus uneven medium chain triglycerides. J. Cereb. Blood Flow Metab. 34 (2014), 153–160.
74. [74] Maciejak, P., Szyndler, J., Turzyńska, D., Sobolewska, A., Kołosowska, K., Krząścik, P., et al. Is the interaction between fatty acids and tryptophan responsible for the efficacy of a ketogenic diet in epilepsy? The new hypotheses of action. Neuroscience 313 (2016), 130–148.
75. [75] Chang, P., Augustin, K., Boddum, K., Williams, S., Sun, M., Terschak, J.A., et al. Seizure control by decanoic acid through direct AMPA receptor inhibition. Brain 139 (2016), 431–443.
76. [76] Stafstrom, C.E., Wang, C., Jensen, F.E., Electrophysiological observations in hippocampal slices from rats treated with the ketogenic diet. Dev. Neurosci. 21 (1999), 393–399.
77. [77] Thio, L.L., Wong, M., Yamada, K.A., Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission. Neurology 54 (2000), 325–331.
78. [78] Masino, S.A., Fortin, J.A., Murphy, M.I., Saa, L., Ruskin, D.N., Autism spectrum disorder and homeostasis. Boison, D., Masino, S.A., (eds.) Homeostatic Control of Brain Function, 2015, Oxford University Press, New York, 586–609.
79. [79] Freeman, J.M., Vining, E.P., Pillas, D.J., Pyzik, P.L., Casey, J.C., Kelly, L.M., The efficacy of the ketogenic diet-1998: a prospective evaluation of intervention in 150 children. Pediatrics 102 (1998), 1358–1363.
80. [80] Hemingway, C., Freeman, J.M., Pillas, D.J., Pyzik, P.L., The ketogenic diet: a 3- to 6-year follow-up of 150 children enrolled prospectively. Pediatrics 108 (2001), 898–905.
81. [81] Neal, E.G., Chaffe, H., Schwartz, R.H., Lawson, M.S., Edwards, N., Fitzsimmons, G., et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 7 (2008), 500–506.
82. [82] Dressler, A., Trimmel-Schwahofer, P., Reithofer, E., Mühlebner, A., Gröppel, G., Reiter-Fink, E., et al. Efficacy and tolerability of the ketogenic diet in Dravet syndrome - comparison with various standard antiepileptic drug regimen. Epilepsy Res. 109 (2015), 81–89.
83. [83] Kossoff, E.H., Rho, J.M., Ketogenic diets: evidence from short- and long-term efficacy. Neurotherapeutics 6 (2009), 406–414.
84. [84] Caraballo, R., Vaccarezza, M., Cersósimo, R., Rios, V., Soraru, A., Arroyo, H., et al. Long-term follow-up of the ketogenic diet for refractory epilepsy: multicenter Argentinean experience in 216 pediatric patients. Seizure 20 (2011), 640–645.
85. [85] Taub, K.S., Kessler, S.K., Bergqvist, A.G.C., Risk of seizure recurrence after achieving initial seizure freedom on the ketogenic diet. Epilepsia 55 (2014), 579–583.
86. [86] Centers for Disease Control and Prevention, Prevalence of autism spectrum disorder among children aged 8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010. Morb. Mortal. Wkly Rep. 63:SS02 (2014), 1–21.